Repertoire Immune Medicines Is A Clinical Stage Biotechnology Company Focused On Developing Programmable Immune Medicines By Harnessing The Human Immune Systemthe Company Aims To Create Innovative Treatments For Cancer And Autoimmune Diseases By Decoding The Unique Codes Within The T Cell Repertoire And Their Interactions Utilizing Its Proprietary Decode Platformrepertoire Gains Insights Into The Immune Synapsewhich Helps Design Targeted Immune Therapiesthe Company S Pipeline Includes Therapeutic Approaches For Various Solid And Hematological Cancersas Well As New Immune Medicines For Autoimmune Conditionsrepertoire Was Formed Through The Partnership Of Cogen Immune Medicine And Torque Therapeuticsenhancing Its Capabilities In Understanding Immune Mechanisms Supported By A Strong Leadership Team And Backed By Flagship Pioneeringrepertoire Immune Medicines Is Dedicated To Advancing The Development Of Transformative Immune Therapies
